Silk Road Medical, Inc (SILK)

Silk Road Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	22.64	20.21	55.36	110.23	69.47	39.18
Short-Term Investments	149.34	161.26	158.32	-	78.02	51.51
Cash & Short-Term Investments	171.98	181.47	213.67	110.23	147.48	90.69
Cash Growth	-8.70%	-15.07%	93.84%	-25.26%	62.62%	262.90%
Receivables	26.25	23.57	18.01	11.83	9.07	8.6
Inventory	29.68	29.88	19.29	17.85	9.99	10.32
Prepaid Expenses	13.1	5.91	3.92	3.41	2.63	2.88
Other Current Assets	-	-	-	-	4.16	-
Total Current Assets	241.02	240.84	254.9	143.33	173.33	112.49
Property, Plant & Equipment	14.3	14.6	14.45	12.92	5.64	6.13
Long-Term Investments	14.18	9.46	-	-	-	18.22
Other Long-Term Assets	0.31	0.42	0.33	0.38	0.34	0.55
Total Assets	269.81	265.31	269.69	156.63	179.31	137.4
Accounts Payable	3.69	5.68	2.52	2.38	2.6	1.9
Accrued Expenses	25.27	22.26	19.33	17.99	13.39	11.54
Current Portion of Long-Term Debt	-	-	-	3.91	-	-
Current Portion of Leases	1.76	1.7	1.84	1.29	0.85	0.77
Current Unearned Revenue	0.27	0.14	0.25	0.16	0.21	0.3
Other Current Liabilities	0.58	0.5	0.54	0.36	2.52	2.42
Total Current Liabilities	31.57	30.28	24.49	26.09	19.56	16.93
Long-Term Debt	76.15	75.63	74.6	44.79	48.53	44.88
Long-Term Leases	6.56	7.3	6	5.75	2.85	3.7
Other Long-Term Liabilities	0.84	0.95	0.73	0.77	0.88	-
Total Liabilities	115.12	114.16	105.81	77.39	71.81	65.51
Common Stock	0.04	0.04	0.04	0.04	0.03	0.03
Additional Paid-In Capital	584.96	550.5	507.72	367.91	346.32	263.38
Retained Earnings	-430.19	-399.46	-343.71	-288.7	-238.89	-191.53
Comprehensive Income & Other	-0.12	0.07	-0.17	-	0.04	0
Total Common Equity	154.68	151.15	163.88	79.24	107.5	71.89
Shareholders' Equity	154.68	151.15	163.88	79.24	107.5	71.89
Total Liabilities & Equity	269.81	265.31	269.69	156.63	179.31	137.4
Total Debt	84.47	84.63	82.44	55.73	52.23	49.35
Net Cash (Debt)	87.52	96.84	131.24	54.5	95.25	41.34
Net Cash Growth	-15.53%	-26.21%	140.80%	-42.78%	130.40%	-
Net Cash Per Share	2.23	2.50	3.67	1.57	2.89	1.80
Filing Date Shares Outstanding	40.63	39.17	38.46	35.01	34.37	31.35
Total Common Shares Outstanding	40.61	39.17	38.36	34.98	34.25	31.26
Working Capital	209.45	210.55	230.41	117.24	153.77	95.56
Book Value Per Share	3.81	3.86	4.27	2.27	3.14	2.30
Tangible Book Value	154.68	151.15	163.88	79.24	107.5	71.89
Tangible Book Value Per Share	3.81	3.86	4.27	2.27	3.14	2.30
Machinery	-	7.83	6.87	3.95	2.43	1.95
Construction In Progress	-	0.34	0.32	4.74	0.48	0.32
Leasehold Improvements	-	7.56	7.25	2.05	2.04	1.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q